European Medicines Agency gives favourable ruling on NSAIDsBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7574.873-a (Published 26 October 2006) Cite this as: BMJ 2006;333:873
- Rory Watson
The London based European Medicines Agency, after a month long investigation, has decided that the benefit-risk balance of non-selective non-steroidal antiinflammatory drugs (NSAIDs) remains favourable.
The review, which was requested in September by France's national medicines agency, takes account of the publication of new data and analyses on thrombotic cardiovascular safety and develops initial recommendations made …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial